Search

Avalon GloboCare: A Trifecta Biotech

Summary

  • Avalon GloboCare is an investment gem because it is brewing a highly diversified pipeline of potential blockbusters.

  • Leveraging precision medicine, Avalon employs liquid biopsy with exosomes biomarkers to provide an accurate diagnosis for various cancers and even nonalcoholic steatohepatitis.

  • The crown jewel of the immunotherapy franchise is a premier multi-target CAR-T. It has the power to circumvent prior limitations of the first generation drugs (Yescarta and Kymriah).

  • Remarkably, Avalon is cutting into the gargantuan regenerative medicine market as it harnesses the power of stem cell-derived exosomes.

  • With unique infrastructure and research programs, Avalon is positioned for colossal growth ahead. The financials and valuation indicate highly asymmetric rewards to risks profile.


Source (Full Article): https://seekingalpha.com/article/4271992-avalon-globocare-trifecta-biotech


Recent Posts

See All

for Required Driver License Testing Across Indonesia NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solut

Program Helps Students Learn How to Solve Complex Optimization Problems with Access to Qatalyst and Quantum Educational Resources LEESBURG, Va., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Quantum Computing Inc